China SXT Pharmaceuticals, Inc. announced earnings results for the half year ended September 30, 2020. For the half year, the company announced total revenue was USD 3.860 million compared to USD 3.215 million a year ago. Operating income was USD 1.163 million compared to operating loss of USD 220,753 a year ago. Net income was USD 1.381 million compared to net loss of USD 2.348 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.1 a year ago.